Healthcare Blogs and Articles
Healthcare Blogs and Articles
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
RevolutionEHR introduced RevPay, an embedded payments solution that integrates checkout, patient records, and reporting within its AI‑native platform. The tool supports card, ACH, digital wallets and offers optional patient surcharging, promising to reduce processing fees that can cost $10,000‑$18,000 annually for a $1 million practice. By providing real‑time transaction dashboards and automatic ledger mapping, RevPay aims to streamline revenue collection and free staff for patient care. The launch positions RevolutionEHR as a comprehensive financial and clinical workflow hub for optometry practices.
Kenco’s vice‑president of life sciences, Tim McClatchy, detailed how the firm is hardening cybersecurity across its manufacturer‑to‑home delivery network while deploying AI to streamline labor planning and route optimization. He explained the specific encryption and verification steps used at each...
Median Technologies announced it will present at TD Cowen’s 46th Annual Health Care Conference in Boston from March 2‑4, 2026. CEO Fredrik Brag will discuss the company’s latest AI‑driven SaMD developments and upcoming milestones on March 4 at 11:10 am ET. The presentation will be...
The FDA approved Hernexeos through the national priority voucher program, a mechanism that fast‑tracks drugs addressing unmet medical needs. Industry leaders are evaluating direct‑to‑consumer (DTC) models to broaden access to HIV prevention tools, leveraging digital and telehealth channels. Additionally, the...
Three bispecific antibodies targeting PD‑1 and CTLA‑4—lorigerlimab, volrustomig, and cadonilimab—illustrate divergent engineering strategies. Lorig erlimab relies on a knob‑into‑hole heterodimer, volrustomig adopts a common light chain format, and cadonilimab incorporates Fc‑silencing mutations. Their distinct designs have produced markedly different safety...
CFG Health launched CareLink, a proprietary 24/7 telehealth platform designed for correctional facilities. Built on existing security‑issued tablets, the solution delivers emergency triage, primary, behavioral, and specialty care while maintaining HIPAA compliance. The platform combines CFG’s in‑house clinicians with external...
Acupath Laboratories has partnered with Azer Scientific to install the first AzerView LH510 digital pathology scanner in the United States. The LH510 offers high‑resolution whole‑slide imaging and streamlined workflow features designed for clinical, academic, and reference labs. The installation marks...
In February 2024 CMS unveiled “shadow bundles,” a modified BPCI‑A methodology that collects episode cost and quality data for hospitals and specialists without their explicit participation. The information is shared primarily with ACOs, MSSP participants, Medicare Advantage plans, and large...
The Inflation Reduction Act reshapes Medicare Part D by granting CMS authority to negotiate prices for high‑cost drugs and instituting a $2,100 annual out‑of‑pocket cap for beneficiaries starting this year. The first ten drugs, including Ozempic and Wegovy, will have negotiated...
Recent research highlights that BMI alone misclassifies up to 34% of adults, masking critical changes in muscle mass and fluid balance. Rapid weight loss driven by GLP‑1 therapies can cause substantial muscle and intracellular water loss while extracellular fluid rises,...
The article explains how repeated failed quit attempts create learned helplessness among smokers, undermining their belief that effort matters. It contrasts this with self‑efficacy, a task‑specific confidence that predicts successful cessation. Pharmacotherapy combined with structured counseling can double quit rates,...
Anesthesiologist Jim Ellwood explains that ketamine, like propofol and fentanyl, is safe when administered by trained professionals but becomes dangerous in unregulated settings. He contrasts high‑profile overdose headlines with the controlled, low‑dose protocols used for anesthesia and emerging mental‑health treatments....
The San Francisco Tech Council launched a state‑funded program that teaches low‑income, limited‑English‑proficiency patients how to use online medical portals. Participants received a 45‑minute hands‑on session with a digital navigator, enabling them to schedule appointments, view results, and request prescriptions. Feedback...
Eli Lilly’s oral GLP‑1 small‑molecule orforglipron demonstrated greater A1C reduction and weight loss than oral semaglutide, while offering flexible dosing without fasting. GSK announced a $950 million acquisition of 35Pharma, securing HS235, an activin‑signaling inhibitor aimed at pulmonary hypertension. The deal taps...
Cowellnex Co., Ltd. and Metagen, Inc. will begin joint research in February 2026 to create new gut‑microbiota test items and a personalized food‑recommendation algorithm using Cowellnex’s three‑year shotgun metagenomic dataset. The partnership leverages Cowellnex’s high‑precision Japanese microbiome data and Metagen’s...
A hospital leader asked ChatGPT how to use Lean to cut staff, and the generic model produced a detailed, seemingly helpful headcount‑reduction plan despite warning against layoffs. The author compared this response to a purpose‑built Lean Hospitals AI, which consistently...
Sun Nuclear launched its 15th QA & Dosimetry Symposium (QADS) in Rome, gathering more than 230 clinical physicists from nearly 40 countries. The event introduced the Daily QA 4 Pro, a combined dosimetry‑imaging device designed to streamline daily machine quality checks. Demonstrations also...
Boston’s life‑sciences sector is adding thousands of well‑paying technician positions that often don’t require a four‑year degree. To address the fragmented training ecosystem, the city funded the Life Sciences Career Alliance with $4.7 million, appointing Year Up United as the coordinating...
The January 2026 Patent Highlights roundup spotlights a wave of new intellectual‑property activity across several cutting‑edge drug discovery areas. Notable filings include lysine‑directed covalent inhibitor chemotypes, strategies to balance potency with drug‑like properties, refined target‑selection frameworks, dozens of Polθ synthetic‑lethal patents...
The new book Physicians With Lived Experience by Dr. Michael F. Myers compiles personal narratives that illuminate the hidden crisis of physician mental health and suicide. Forewords by Jennifer Breen Feist and Dr. Darrell Kirch highlight the power of storytelling, the passage...
Oregon and Oklahoma are set to launch their own state‑based ACA exchanges, bringing the total to 23 states (including DC) that will operate independent marketplaces by 2028. This shift will push state‑run exchanges past the 50 percent population mark, a milestone...
Physician Francisco M. Torres argues that the bedside physical exam remains a vital diagnostic tool despite rapid advances in imaging and lab tests. He recounts two personal cases—a misdiagnosed sciatica caused by shingles and a postoperative fluid collection missed without...
A recent OurCare survey found 5.9 million Canadians lack a primary‑care provider, and those with one face long waits and rushed visits, driving emergency‑department crowding. The federal government responded by creating 5,000 Express Entry slots for international doctors, but experts argue...
An international team led by the University of Birmingham, University Hospitals Birmingham NHS Foundation Trust and Bristol Myers Squibb has produced the most detailed spatial atlas of pancreatic ductal adenocarcinoma (PDAC) to date. Using spatial transcriptomics and spatial molecular imaging...
Owners of a concierge medical practice attempted a sale, but the first Letter of Intent (LOI) collapsed, leaving them to restart the process. They turned to Axial's Advisor Finder, which quickly presented four vetted M&A advisors with healthcare expertise. After...
Dr. Daganzo recounts paying $78 for identical lab tests through a direct‑pay platform versus an estimated $900 cash price at Quest Diagnostics, highlighting extreme price opacity in traditional settings. Patients increasingly bypass insurance‑based pathways, preferring transparent, upfront pricing and predictable...
The United States still uses an opt‑in organ donation system, meaning individuals must actively register to become donors. Behavioral‑economics research shows that default settings heavily influence decisions, and the opt‑in model creates inertia at points like DMV renewals. Countries that...
YOU(th) has secured US$4.5 million to scale its AI‑driven smartphone health‑screening platform, which evaluates over 50 digital biomarkers in under two minutes. The round was led by Callisto Health with participation from caesar., adesso Ventures, Antler, Moonstone, 1024 Ventures and notable...
The post‑holiday period often reveals hidden cardiovascular strain from excess calories, alcohol, and disrupted sleep. These habits can raise blood pressure, cholesterol, and glucose, creating a short‑term risk window. Men face higher risk due to binge‑drinking patterns and delayed preventive...
A new study shows that maternal obesity dramatically shortens the lifespan of mouse offspring, even when the pups are switched to a healthy diet after weaning. The reduction in longevity is linked to early‑life epigenetic programming that triggers widespread organ...
Chronic liver disease in the UK is often identified only after emergency admission, with more than a third of such patients dying within a year. Stigma and competing primary‑care priorities leave up to 80 % of MASH cases undiagnosed, driving rising...
Buzz Health President Joseph Kleiman says TrumpRx is advancing drug‑price transparency by giving consumers early visibility into prescription costs. He notes that real‑time pricing can help patients compare options but also warns that prices are dynamic and may change before...
Otsuka America became the first major pharmaceutical company to back psychedelic‑inspired medicines in 2020 through a partnership with COMPASS Pathways, and deepened that commitment by acquiring Mindset in 2023. The company is applying its long‑standing CNS expertise to develop serotonergic...
Women’s HealthX (WoHX) will convene 750 pharma, biotech, hospital, insurer, startup and government leaders in Boston on December 3‑4, 2026. The two‑day summit aims to close the sex‑difference data gap by showcasing evidence‑based technologies, AI tools and digital therapeutics across the...
The Fifth Circuit rejected the DEA’s long‑standing reading of the pharmacist’s “corresponding responsibility” and “usual course of professional practice” regulations, ruling that liability requires proof a prescription was invalid when issued and that the pharmacist actually knew it was invalid....
The Centers for Medicare & Medicaid Services (CMS) announced a $259.5 million deferral of federal Medicaid matching funds to Minnesota, citing questionable and potentially fraudulent claims. The agency also imposed a six‑month nationwide moratorium on new enrollment for Durable Medical Equipment,...
A dentist refused to perform a routine cleaning without bitewing X‑rays, despite the patient’s low‑risk status and recent radiographs. The practice cited a two‑year imaging policy and warned that proceeding could jeopardize the hygienist’s license. After consulting the supervising dentist,...
Dotinurad (FYU‑981), marketed as Urece®, is a URAT1 inhibitor approved for gout and hyperuricemia in Japan and China. The drug was chemically refined from the older uricosuric benzbromarone to retain potency while eliminating rare hepatotoxic events. Crystalys Therapeutics is now...
Stem cell therapies for neurodegenerative diseases span unregulated, low‑evidence clinics to proprietary, patent‑protected programs seeking regulatory approval. A new narrative review compiles trial outcomes, highlighting modest benefits—primarily brief inflammation reduction—and significant variability across patients and cell batches. The paper also...
The Xtalks Life Science Podcast’s Episode 244 spotlights a persistent gap in epilepsy care for pregnant women, noting that fewer than 5% of clinical trials include this population. Andrea Wilkinson, UCB’s Global Head of Patient Engagement & Advocacy, discusses new...
The FDA has approved Braftovi for patients with BRAF V600E‑mutant metastatic colorectal cancer, expanding targeted options in a genetically defined subset. The clearance underscores the momentum of biomarker‑driven oncology and combination‑therapy strategies. In parallel, Novo Nordisk announced a $2 billion partnership with Vivtex...
A Danish register study of over 800,000 women examined the long‑term safety of menopausal hormone therapy (MHT). About 12% of participants used MHT for a median of 1.7 years, and the analysis found no association between MHT use and all‑cause...
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) seized nearly 2,000 doses of illegal weight‑loss drugs in raids on sites in Lincolnshire and Nottinghamshire, marking its second major operation in four months. The confiscated products were labelled as containing tirzepatide...
Chamber Cardio announced a $60 million Series A round in February 2026, led by Frist Cressey Ventures and backed by General Catalyst, Optum Ventures, Healthworx and other investors. The startup offers a two‑sided platform that connects payers with cardiology practices, embedding workflow‑native AI...
Type 2 diabetes is reframed as chronic elevated blood sugar (CEBS) rather than a disease of insulin deficiency. The article argues that what is labeled "insulin resistance" is a protective cellular response to persistent glucose oversupply caused by excessive carbohydrate consumption....
Brazil spends roughly US$75 billion annually on medicines through its universal health system, but fragmented procurement across 5,000 municipalities creates price volatility and opaque documentation. A coalition of government agencies and civil‑society groups launched the Medicamentos Transparentes platform, which consolidates purchase...
Sibel Health and LookDeep Health announced a strategic partnership that merges Sibel’s FDA‑cleared ANNE® One wearable, which continuously captures clinical‑grade vitals, with LookDeep’s aimee™ bedside AI that adds real‑time visual and audio context. The combined platform targets emergency departments, general...
Diabetes prevalence has surged past 800 million adults, with youth type 2 rates climbing 94 % since 1990, intensifying vascular complications like peripheral artery disease. Surveys reveal 55 % of Americans delay seeking care for leg pain and 80 % of primary‑care clinicians lack confidence...
A Parallels survey of 600+ global IT leaders found 94% fear vendor lock‑in, especially in health systems where platforms now underpin clinical, security and data functions. The study shows a shift from cost‑avoidance to protecting organisational freedom, prompting hybrid and...
The Digital Health Rewired 2026 conference programme, featuring ten themed stages, has been released. More than 300 senior health‑IT leaders, including NHS CEOs, CIOs, CCIOs and CNIOs, will present sessions on digital transformation, cyber security, AI, and electronic patient records....
